𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The tumor suppressor p53 modifies mutational processes in a human lymphoblastoid cell line

✍ Scribed by Fen Xia; Howard L Liber


Book ID
114071123
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
251 KB
Volume
373
Category
Article
ISSN
0027-5107

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Mutations in the p53 tumor suppressor ge
✍ William E. Pierceall; Tapas Mukhopadhyay; Leonard H. Goldberg; Honnavara N. Anan πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 528 KB

In this study, we analyzed 10 human squamous cell carcinomas (SCCs) for alterations in the p53 tumor suppressor gene in exons 4 through 9 by single-strand conformation polymorphism (SSCP) analysis. We found that 2 of 10 SCCs displayed unusual SSCP alleles at exon 7 of the p53 gene. Subsequent clonin

Mutations of the p53 tumor suppressor ge
✍ Hiroko Ohgaki; Robert H. Eibl; Martin B. Reichel; Luigi Mariani; Iver Petersen; πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 650 KB

## Abstract A variety of neoplasms of the human nervous system were analyzed for the presence of mutations in the __p53__ tumor suppressor gene. DNA was extracted from frozen or formalin‐fixed, paraffin‐embedded material. Single‐strand conformation polymorphism (SSCP) analysis for exons 5–8 was fol

Specific killing of P53 mutated tumor ce
✍ Peter A. WΓΌrtzen; Lars Ø. Pedersen; Hans S. Poulsen; Mogens H. Claesson πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 144 KB

p53 is upregulated in the majority of spontaneous tumors and the HLA class I molecule HLA-A2 is expressed by approximately 50% of the caucasians. Potentially, these facts make HLA-A2-binding p53 peptides for CTL-inducing immunotherapy applicable to a broad range of cancer patients. In our study, we